5/8
12:18 pm
acrs
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/7
04:19 pm
acrs
Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update [Yahoo! Finance]
Low
Report
Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update [Yahoo! Finance]
5/7
04:01 pm
acrs
Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
Medium
Report
Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
4/30
07:00 am
acrs
Aclaris Therapeutics to Announce First Quarter 2024 Financial Results on May 7, 2024 and to Provide Corporate Update
Low
Report
Aclaris Therapeutics to Announce First Quarter 2024 Financial Results on May 7, 2024 and to Provide Corporate Update
4/25
07:58 am
acrs
Cryopyrin-Associated Periodic Syndrome Drug Pipeline Report 2024: Therapeutic Developments for Zydus Cadila, Novartis, Inflazome, Roche, Aclaris Therapeutics, and Mabpharm [Yahoo! Finance]
Medium
Report
Cryopyrin-Associated Periodic Syndrome Drug Pipeline Report 2024: Therapeutic Developments for Zydus Cadila, Novartis, Inflazome, Roche, Aclaris Therapeutics, and Mabpharm [Yahoo! Finance]
4/23
08:12 am
acrs
Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer [Yahoo! Finance]
Low
Report
Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer [Yahoo! Finance]
4/23
08:00 am
acrs
Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer
Low
Report
Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer
4/11
10:26 am
acrs
Favourable Signals For Aclaris Therapeutics: Numerous Insiders Acquired Stock [Yahoo! Finance]
Medium
Report
Favourable Signals For Aclaris Therapeutics: Numerous Insiders Acquired Stock [Yahoo! Finance]
4/5
11:59 am
acrs
Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year? [Yahoo! Finance]
Low
Report
Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year? [Yahoo! Finance]
4/2
02:05 am
acrs
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
3/25
11:37 pm
acrs
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/8
02:04 am
acrs
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
3/4
10:51 am
acrs
Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
Low
Report
Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
2/29
11:05 pm
acrs
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
2/29
05:53 am
acrs
Analysts Have Just Cut Their Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Revenue Estimates By 51% [Yahoo! Finance]
Neutral
Report
Analysts Have Just Cut Their Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Revenue Estimates By 51% [Yahoo! Finance]
2/27
07:12 am
acrs
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update [Yahoo! Finance]
Medium
Report
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update [Yahoo! Finance]
2/27
07:12 am
acrs
Can Aclaris Therapeutics (NASDAQ:ACRS) Afford To Invest In Growth? [Yahoo! Finance]
Low
Report
Can Aclaris Therapeutics (NASDAQ:ACRS) Afford To Invest In Growth? [Yahoo! Finance]
2/27
07:00 am
acrs
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Medium
Report
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update